Rising Pharma Holding, Inc. FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection NAI · Nov 3, 2023
  • No warning letters matched by name
Inspections 1 0 OAI
Recalls 13 0 Class I (0%)
Warning letters 0 None on file
510(k) clearances 0 None on file

Rising Pharma Holding, Inc. has 13 FDA recalls, 1 inspection, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Rising Pharma Holding, Inc." is on file.

What these totals cover: FDA records filed under the name "Rising Pharma Holding, Inc." and its spelling variant "Rising Pharma Holding".

Latest recall
D-0724-2026 · Class II · Jul 13, 2026
Latest inspection
Nov 3, 2023 · NAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls13Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections1Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Rising Pharma Holding, Inc.'s FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Rising Pharma Holding, Inc.: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 1 inspection (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 8 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 2 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 2 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600020
202500020
202400080
202310010
202200000
202100000
202000000
201900000
201800000
201700000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Rising Pharma Holding, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Rising Pharma Holding, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent recalls

13 recall records from Dec 29, 2023 to Jul 13, 2026.

NumberClassProductDate
D-0724-2026Class IIRising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manufactured for…Jul 13, 2026
D-0384-2026Class IIProduct label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for…Mar 3, 2026
D-0029-2026Class IICarbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only…Oct 7, 2025
D-0277-2025Class IIDuloxetine Delayed-Release Capsules, USP, 30 mg, 1,000-count bottle, Rx only, Distributed by: Rising…Mar 5, 2025
D-0189-2025Class IIDuloxetine Delayed-Release Capsules USP 20 mg, 60 count bottles, Rx only, Distributed by: Rising…Dec 30, 2024
D-0190-2025Class IIDuloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30) and b) 1000 count (NDC…Dec 30, 2024
D-0188-2025Class IIDuloxetine Delayed-Release Capsules USP 30 mg, a) 30 count (NDC 57237-018-30) and b) 1000 count (NDC…Dec 30, 2024
D-0106-2025Class IIDuloxetine Delayed-Release Capsules USP, 30 mg, a) 30 count (NDC 57237-018-30), b) 90 count (NDC…Nov 19, 2024
D-0105-2025Class IIDuloxetine Delayed-Release Capsules USP, 20 mg, 60 count bottles, Rx only, Distributed by: Rising…Nov 19, 2024
D-0107-2025Class IIDuloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30), b) 90 count NDC 57237-019-90 and…Nov 19, 2024
D-0599-2024Class IIIDiflorasone Diacetate Ointment, USP, 0.05%, 60g tube, Rx only, Mfd. By: Lyne Laboratories, Inc…Jun 24, 2024
D-0541-2024Class IIIPregabalin Capsules 50mg, 1000-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings…May 16, 2024
D-0222-2024Class IIbuPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only…Dec 29, 2023

Recent FDA inspections

1 inspection on Nov 3, 2023.

DateSiteProductClassificationFEI
Nov 3, 2023East Brunswick, NJDrugsNo Action Indicated (NAI)3015784623
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3015784623East Brunswick, NJ1Nov 3, 2023

Rising Pharma Holding, Inc. and the FDA: common questions

Has Rising Pharma Holding, Inc. received an FDA warning letter?

No FDA warning letter addressed to the name "Rising Pharma Holding, Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Rising Pharma Holding, Inc. received an FDA Form 483?

FDA has not published a Form 483 for "Rising Pharma Holding, Inc." in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Rising Pharma Holding, Inc.?

The most recent FDA inspection on file ended Nov 3, 2023 at East Brunswick, NJ and was classified NAI. FDA has 1 inspection of Rising Pharma Holding, Inc. on file.

Has Rising Pharma Holding, Inc. had an FDA recall?

Yes. Rising Pharma Holding, Inc. has 13 FDA recalls on record. The most recent started Jul 13, 2026.

Need more than this page shows? Ask about Rising Pharma Holding, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.